|
Index of reports
> Cases with Neutropenia (16)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Rituxan side effects in 81 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-22
Patient: 81 year old male
Reactions: Vision Blurred, Neutropenia, Thrombocytopenia, Fall, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from Italy on 2012-07-23
Patient:
Reactions: Neutropenia, Respiratory Tract Infection
Drug(s) suspected as cause:
Cladribine
Dosage: for 5 consecutive days administered monthly for 4 cycles
Indication: Waldenstrom's Macroglobulinaemia
Rituxan
Dosage: on day 1 administered monthly for 4 cycles by infusion
Indication: Waldenstrom's Macroglobulinaemia
Possible Rituxan side effects in
Reported by a physician from Japan on 2012-07-17
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: B-Cell Lymphoma
Rituxan
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Possible Rituxan side effects in male
Reported by a physician from Germany on 2012-07-10
Patient: male
Reactions: Neutropenia, Lymphocytic Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-20
End date: 2012-04-20
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Rituxan
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-16
Prednisolone
Dosage: 50 mg, bid
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-21
Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole
Possible Rituxan side effects in 54 year old male
Reported by a pharmacist from Canada on 2012-07-10
Patient: 54 year old male
Reactions: White Blood Cell Count Decreased, Peritonitis Bacterial, Hypotension, Hernial Eventration, Neutropenia, Septic Shock, Respiratory Distress, Loss of Consciousness
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Vincristine Sulfate
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Product Used FOR Unknown Indication
Doxorubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Fluconazole; Furosemide; Nadolol; Omeprazole; Amiloride Hydrochloride; Ciprofloxacin; Acyclovir; Lactulose
Possible Rituxan side effects in 43 year old female
Reported by a pharmacist from Canada on 2012-07-09
Patient: 43 year old female, weighing 112.0 kg (246.4 pounds)
Reactions: Oral Candidiasis, Herpes Simplex, Mouth Ulceration, Oropharyngeal Pain, Neutropenia, Neoplasm
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a pharmacist from United States on 2012-05-21
Patient: male
Reactions: Neutropenia
Drug(s) suspected as cause:
Rituxan
Treanda
Possible Rituxan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 54 year old male, weighing 91.9 kg (202.2 pounds)
Reactions: Asthma, Dyspnoea, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 20 milligram
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-25
Revlimid
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-08-17
Rituxan
Dosage: 375 milligram/sq. meter
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-25
Revlimid
Dosage: 15 milligram
Administration route: Oral
Other drugs received by patient: Potassium Chloride; Simvastatin; Altace; Zofran; Albuterol; Acidophilus; Zocor; Glucosamine; Insulin; Ultram; Tramadol Hydrochloride; Aspirin; Ciprofloxacin; Hydrochlorothiazide; Ondansetron; Visine EYE Drops; Calcium + Vitamin D; Ondansetron; Ramipril; Humalog; Tessalon; Steroid; Toradol; Singulair; Multi-Vitamins; Novolog; Steroid
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-02
Patient: female
Reactions: Vomiting, Nausea, Anaemia, Constipation, Death, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 25 year old female
Reported by a pharmacist from Canada on 2012-04-27
Patient: 25 year old female
Reactions: Vomiting, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: Product Used FOR Unknown Indication
Prednisone
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Product Used FOR Unknown Indication
Doxorubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate Sodium; Methotrexate; Nabilone; Allopurinol; Oxycodone HCL; Lactulose; Prevacid
Possible Rituxan side effects in 63 year old female
Reported by a pharmacist from Canada on 2012-04-10
Patient: 63 year old female
Reactions: Pneumocystis Jiroveci Pneumonia, Respiratory Failure, Neutropenia, Cognitive Disorder, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: (the patient received rituximab on 13 january 2012).
Start date: 2011-12-30
Rituxan
Dosage: (the patient received rituximab on 21 july 2011, 25 july 2011 and 27 july 2011).
Indication: Epstein-Barr Virus Infection
Start date: 2011-07-19
Other drugs received by patient: Proctosone; Cefazolin; Ceftazidime; Albuterol; Primaquine; Levofloxacin; Lansoprazole; Piperacillin and Tazobactam; Nabilone; Prednisone TAB; Hydromorphone HCL; Ipratropium Bromide; Clindamycin; Nystatin; Solu-Medrol
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: male, weighing 77.4 kg (170.3 pounds)
Reactions: Abdominal Pain, Economic Problem, Refusal of Treatment by Patient, Anaemia Haemolytic Autoimmune, Burkitt's Lymphoma, Metastases To Pelvis, Ascites, Treatment Related Secondary Malignancy, Chronic Lymphocytic Leukaemia Recurrent, Metastases To Peritoneum, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 600 mg/m2 on weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Rituxan
Dosage: 375 mg/m2 over 4 hr/on one day on weeks 1, 5, 9, 13,17 and 21 (unknown) intravenous (not otherwise s
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Pentostatin
Dosage: 4mg/m2 x 1 day weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-06-16
End date: 2008-11-17
Possible Rituxan side effects in 83 year old female
Reported by a consumer/non-health professional from United States on 2012-03-09
Patient: 83 year old female
Reactions: Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a physician from United Kingdom on 2012-02-27
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: Diarrhoea, Mouth Ulceration, Neutropenic Sepsis, Lymphopenia, Anaemia, Pyrexia, Neutropenia, Lethargy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Vincristine
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Rituxan
Indication: B-Cell Lymphoma
Start date: 2010-05-20
Prednisolone
Indication: B-Cell Lymphoma
Other drugs received by patient: Acetaminophen; Chlorpheniramine Maleate; Cotrim
Possible Rituxan side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02
Patient: 31 year old male
Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 420 mg, unk
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituxan
Dosage: 788 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Doxorubicin HCL
Dosage: 103 mg, unk
Indication: non-Hodgkin's Lymphoma
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 6.3 g, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 618 mg, unk
Indication: non-Hodgkin's Lymphoma
Leucovorin Sodium
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Mesna
Dosage: 1236 mg, unk
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix
Possible Rituxan side effects in 48 year old female
Reported by a physician from United States on 2011-10-28
Patient: 48 year old female
Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure
Drug(s) suspected as cause:
Dapsone
Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
Indication: Behcet's Syndrome
Arava
Dosage: 20 mg daily
Indication: Behcet's Syndrome
Imuran
Dosage: titrated up to 150 mg daily
Indication: Behcet's Syndrome
Plaquenil
Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
Administration route: Oral
Indication: Behcet's Syndrome
Enbrel
Dosage: 25 mg twice weekly
Indication: Behcet's Syndrome
Methotrexate
Dosage: 7.5 mg per week, titrated up to 20 mg per week
Indication: Behcet's Syndrome
Cytoxan
Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
Indication: Behcet's Syndrome
Cyclosporine
Indication: Behcet's Syndrome
End date: 2001-01-06
Remicade
Dosage: 200 mg, 300 mg, 400 mg, intravenous
Indication: Behcet's Syndrome
Leukeran
Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
Indication: Behcet's Syndrome
Colchicine
Dosage: 6 mg twice daily, 6 mg twice daily
Indication: Behcet's Syndrome
Cellcept
Dosage: 1000 mg twice daily
Indication: Behcet's Syndrome
Rituxan
Dosage: 1000 mg, 1000 mg, intravenous
Indication: Behcet's Syndrome
End date: 2006-07-05
Prednisone
Dosage: 10 mg daily
Indication: Behcet's Syndrome
Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate
|
